Inactief instrument
Koers Merrimack Pharmaceuticals
Aandelen
MACK
US5903282094
Biotechnologie & Medisch Onderzoek
| Bedrijfsleider | Titel | Leeftijd | Van |
|---|---|---|---|
Gary Crocker
CEO | Algemeen Directeur | 74 | 28-06-2019 |
Timothy Surgenor
IRC | Investor Relations Contact | - | - |
| Bestuurder | Titel | Leeftijd | Van |
|---|---|---|---|
Gary Crocker
CHM | Voorzitter | 74 | 01-01-2005 |
| Datum | Insider | Type | Hoofdpost | Volume | % marktkap. | Belang |
|---|---|---|---|---|---|---|
| 26/12/23 | Western Standard LLC
| Koop | Onderneming | 49.550 | 0,3460% | |
| 7/12/23 | Western Standard LLC
| Koop | Onderneming | 101.050 | 0,7056% | |
| 17/11/23 | Western Standard LLC
| Koop | Onderneming | 300 | 0,0021% |
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Varia. 1j. | Varia. 3j. | Kap.($) | |
|---|---|---|---|---|---|---|
| -.--% | +0,20% | - | - | 224 mln. | ||
| +1,15% | -2,81% | +53,73% | +71,00% | 65,56 mld. | ||
| -2,64% | +0,07% | +9,57% | +89,87% | 60,41 mld. | ||
| -1,07% | +0,55% | +21,79% | +87,66% | 55,76 mld. | ||
| +0,48% | -0,98% | +12,97% | +118,46% | 46,98 mld. | ||
| -2,69% | -7,62% | +16,77% | +25,79% | 43,63 mld. | ||
| -0,70% | +1,43% | +14,05% | +45,20% | 36,7 mld. | ||
| -2,50% | -18,72% | +140,13% | +665,60% | 36,09 mld. | ||
| -0,77% | -4,34% | +79,27% | +59,47% | 32,9 mld. | ||
| -0,83% | +4,96% | -36,93% | +398,61% | 26,96 mld. | ||
| Gemiddelde | -0,96% | -1,71% | +34,59% | +173,52% | 45 mld. | |
| Gewogen gemiddelde per kap. | -0,99% | -1,48% | +34,18% | +148,27% |
Werknemers
27
















